Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4
Mohammad Reza Mohammad Hoseini Azar, Hamed Aghazadeh, Halgurd Nadhim Mohammed, et al.
International Immunopharmacology (2021) Vol. 92, pp. 107355-107355
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Novel strategies to reverse chemoresistance in colorectal cancer
Shu‐Chang Ma, Jiaqi Zhang, Tianhua Yan, et al.
Cancer Medicine (2023) Vol. 12, Iss. 10, pp. 11073-11096
Open Access | Times Cited: 60
Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression
Reem Khaled M.E. Alsayed, Abdul Quaiyoom Khan, Fareed Ahmad, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 697-708
Open Access | Times Cited: 30
Recent Advances in CXCL12/CXCR4 Antagonists and Nano-Based Drug Delivery Systems for Cancer Therapy
Ruogang Zhao, Jianhao Liu, Zhaohuan Li, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1541-1541
Open Access | Times Cited: 30
The pathological role of C-X-C chemokine receptor type 4 (CXCR4) in colorectal cancer (CRC) progression; special focus on molecular mechanisms and possible therapeutics
Ahmed Hjazi, F. Nasir, Rabia Noor, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154616-154616
Closed Access | Times Cited: 17
CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
Sadegh Shojaei Baghini, Zhanna R. Gardanova, Saeme Azizi Hassan Abadi, et al.
Cellular & Molecular Biology Letters (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 24
MicroRNA-nanoparticles against cancer: Opportunities and challenges for personalized medicine
Elisa Martino, Nunzia D’Onofrio, Camilla Anastasio, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 371-384
Open Access | Times Cited: 16
Demystifying the CXCR4 conundrum in cancer biology: Beyond the surface signaling paradigm
Mushtaq Ahmad Nengroo, Muqtada Ali Khan, Ayushi Verma, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1877, Iss. 5, pp. 188790-188790
Closed Access | Times Cited: 20
MicroRNAs as Predictive Biomarkers in Patients with Colorectal Cancer Receiving Chemotherapy or Chemoradiotherapy: A Narrative Literature Review
I‐Ping Yang, Kwan-Ling Yip, Yu‐Tang Chang, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1358-1358
Open Access | Times Cited: 11
Exosomes and their distinct integrins transfer the characteristics of oxaliplatin- and 5-FU-resistant behaviors in colorectal cancer cells
Zeynab Vakili-Ghartavol, Hoda Deli, Amir Shadboorestan, et al.
Molecular Medicine (2025) Vol. 31, Iss. 1
Open Access
miR‐135b‐5p/PDE3B Axis Regulates Gemcitabine Resistance in Pancreatic Cancer Through Epithelial‐Mesenchymal Transition
Yuxuan Fu, Liangsheng Chen, Ning Lv, et al.
Molecular Carcinogenesis (2025)
Closed Access
MicroRNAs and JAK/STAT3 signaling: A new promising therapeutic axis in blood cancers
Mehdi Sajjadi-Dokht, Talar Ahmad Merza Mohammad, Heshu Sulaiman Rahman, et al.
Genes & Diseases (2021) Vol. 9, Iss. 4, pp. 849-867
Open Access | Times Cited: 24
Integration of chemokine signaling with non-coding RNAs in tumor microenvironment and heterogeneity in different cancers
Shweta Arora, Salman Khan, Almaz Zaki, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 720-736
Closed Access | Times Cited: 17
Targeting oncogenic functions of miR-301a in head and neck squamous cell carcinoma by PI3K/PTEN and MEK/ERK pathways
Rocío Granda‐Díaz, Lorea Manterola, Francisco Hermida‐Prado, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 161, pp. 114512-114512
Open Access | Times Cited: 9
Restoration of miR-648 overcomes 5-FU-resistance through targeting ET-1 in gastric cancer cells in-vitro
Parsa Aliabadi, Maryam Sadri, Goli Siri, et al.
Pathology - Research and Practice (2022) Vol. 239, pp. 154139-154139
Closed Access | Times Cited: 15
Emerging roles of non-coding RNAs in colorectal cancer oxaliplatin resistance and liquid biopsy potential
Zheng-Dong Luo, Yifeng Wang, Yu-Xiao Zhao, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 1, pp. 1-18
Open Access | Times Cited: 8
Double-edged sword role of miRNA-633 and miRNA-181 in human cancers
Jitendra Gupta, Muath Suliman, Rida Ali, et al.
Pathology - Research and Practice (2023) Vol. 248, pp. 154701-154701
Closed Access | Times Cited: 8
Interplays between non-coding RNAs and chemokines in digestive system cancers
Abdollah Jafarzadeh, Seyedvahid Seyedmoalemi, Amirreza Dashti, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113237-113237
Closed Access | Times Cited: 13
Exosomal non-coding RNAs: Blueprint in colorectal cancer metastasis and therapeutic targets
Bashdar Mahmud Hussen, Sara Tharwat Abdullah, Snur Rasool Abdullah, et al.
Non-coding RNA Research (2023) Vol. 8, Iss. 4, pp. 615-632
Open Access | Times Cited: 7
Identification of a novel miRNA-based recurrence and prognosis prediction biomarker for hepatocellular carcinoma
Xuanfeng Zhang, Dong Zhang, Xuefeng Bu, et al.
BMC Bioinformatics (2022) Vol. 23, Iss. 1
Open Access | Times Cited: 11
KDM6B promotes gastric carcinogenesis and metastasis via upregulation of CXCR4 expression
Fen Liu, Yue Wang, Zongcheng Yang, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 11
RNA therapeutics in targeting G protein-coupled receptors: Recent advances and challenges
Wanjun Yuan, Xiangyang Shi, Leo Tsz On Lee
Molecular Therapy — Nucleic Acids (2024) Vol. 35, Iss. 2, pp. 102195-102195
Open Access | Times Cited: 2
Comprehensive bioinformatics analysis of functional molecules in colorectal cancer
Tao Meng, Zhangzhang Lan, Xiaoling Zhao, et al.
Journal of Gastrointestinal Oncology (2022) Vol. 13, Iss. 1, pp. 231-245
Open Access | Times Cited: 10
Parietal Epithelial Cell Behavior and Its Modulation by microRNA-193a
Joyita Bharati, Praveen Chander, Pravin C. Singhal
Biomolecules (2023) Vol. 13, Iss. 2, pp. 266-266
Open Access | Times Cited: 6
miR-197-3p Promotes Osteosarcoma Stemness and Chemoresistance by Inhibiting SPOPL
Jingyong Zhang, Shubao Wang, Yang Bai, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 3, pp. 1177-1177
Open Access | Times Cited: 6
A comprehensive survey into the role of microRNAs in ovarian cancer chemoresistance; an updated overview
Ahmad Saburi, Mohammad Saeed Kahrizi, Navid Naghsh, et al.
Journal of Ovarian Research (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top